Morgan Stanley Neuroone Medical Technologies Corp Call Options Transaction History
Morgan Stanley
- $1.35 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NMTC
# of Institutions
22Shares Held
2.42MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA920KShares$1.11 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT799KShares$966,5020.05% of portfolio
-
Geode Capital Management, LLC Boston, MA284KShares$343,4640.0% of portfolio
-
Perkins Capital Management Inc150KShares$181,5000.15% of portfolio
-
State Street Corp Boston, MA59.5KShares$71,9930.0% of portfolio
About NEUROONE MEDICAL TECHNOLOGIES Corp
- Ticker NMTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,209,200
- Market Cap $19.6M
- Description
- NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for pat...